$1.51
-0.09-5.63%
Last update: Nov 5, 5:07 PM
TransCode Therapeutics Inc
RNAZNASDAQ
TransCode Therapeutics (RNAZ) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-7.17 | $-21.28 | $-18.10 | $-5.82 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 14, 2025 | $-70.28 | $-41.44 | -69.6 % |
| Q4 | Apr 15, 2025 | $-201.88 | $-3.21 | -6189.1 % |
| Q3 | Nov 14, 2024 | $-147.84 | $-452.76 | 67.3 % |
| Q2 | Aug 14, 2024 | $-683.76 | $-535.92 | -27.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Apr 15, 2025 | $0 | $300.00K | -100.0 % |
| Q3 | Nov 14, 2024 | $0 | $300.00K | -100.0 % |
